MEDvidi is a telehealth platform setting a new standard for safe, effective, and scalable mental health care in the United States. With the help of licensed medical providers and proprietary AI systems, MEDvidi delivers consistent, outcomes-driven treatment for conditions like ADHD, anxiety, depression, insomnia, and more. Our focus includes mental health evaluation and evidence-based medication management, where every visit is anchored in data, not guesswork.
Behind the scenes, MEDvidi optimizes the heavy administrative workload that slows down care. The platform automates patient identity and eligibility verification; runs PDMP checks across multiple states for controlled-substance safety; generates high-quality charts from structured intake and visit audio; and orchestrates follow-ups, refill workflows, and treatment plans. Our Chart Review AI Assistant makes it possible to audit 100% of visits (instead of ~5% historically), catching issues early and reinforcing best practices at scale. Scheduling and care coordination are streamlined, keeping healthcare providers focused on clinical decision-making, not paperwork.
For patients, that means faster access, clearer care plans, and ongoing progress tracking through validated measures (e.g., PHQ-9, GAD-7). For clinicians, it reduces administrative burden and creates more clinical time. For partners, this ensures transparency, quality, and operational efficiency. Today, MEDvidi serves more than 100,000 patients nationwide, with AI meaningfully improving access, affordability, margins, and outcomes.
Our north star is simple: give every patient timely, appropriate mental health care delivered by skilled clinicians and amplified by technology. MEDvidi aims to make telehealth services safer and measurably better, built with privacy, security, and clinical governance in mind, aligned to state prescribing rules.
